Market Research Logo

Global In-Vitro Diagnostic (IVD) Market: Size, Trends & Forecasts (2017-2021)

Global In-Vitro Diagnostic (IVD) Market: Size, Trends & Forecasts (2017-2021)

Scope of the Report

The report entitled “Global In-Vitro Diagnostic (IVD) Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the global In-Vitro Diagnostic, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, by products, by technology and by region. The report also provides the analysis of the global in-vitro diagnostic market of the US, Europe, Asia and ROW regions.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global in-vitro diagnostic has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Roche Holding, Danaher Corporation, Abbott Laboratories and Siemens Group are some of the key players operating in the global in-vitro diagnostic market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Country Coverage

The US
Europe
Asia
ROW

Company Coverage

Roche Holding
Danaher Corporation
Abbott Laboratories
Siemens Group

Executive Summary

Clinical trials are defined as research examinations in which individuals volunteer to test new medications, interferences or tests as a way to prevent, distinguish, treat or oversee different illnesses or medical conditions. The clinical trials can broadly be classified into two categories named as In Vivo and In Vitro.

In vivo indicates to a medical test, trial or strategy that is done on (or in) a living being, for example, a research laboratory animal or human. In vitro refers to a medicinal report or examination which is done in the research facility inside the confines of a test tube or lab dish.

In Vitro Diagnostics (IVD) are medical devices and accessories used to perform tests on biological samples (such as tissues, blood or urine) to determine the status of a person health. The in vitro diagnostics can further be divided on the basis of products, by technology and by end users.

The In Vitro Diagnostics (IVD) is generally divided into three types of products namely, reagents, Instrumentations and Software Services. The IVD is primarily segmented into eight technologies Immunodiagnostics, Self-Monitoring Blood Glucose (SMBG), Point-of-Care, Molecular Diagnostics, Microbiology, Clinical Chemistry, Hematology and Other. The in vitro diagnostic end users are broadly classified into three categories named as Laboratory, Hospitals and Patients Self-Testing.

The global in-vitro diagnostics (IVD) market is expected to increase at high growth rates during the forecasted period (2017-2021). The global in-vitro diagnostics is supported by various growth drivers, such as, increasing disposable income, increasing obese population, swelling diabetic population, rising healthcare expenditure, etc.


1. Executive Summary
2. Introduction
2.1 Clinical Trials: An Overview
Table 1: Categories of Clinical Trials
2.2 In-Vitro: An Overview
Table 2: In-Vitro Outline
2.3 In-Vitro Diagnostic (IVD): An Overview
Table 3: Classification of In-Vitro Diagnostics (IVD)
2.4 In-Vitro Diagnostic (IVD) Products: An Overview
Table 4: In-Vitro Diagnostic (IVD) Products
2.5 In-Vitro Diagnostic (IVD) Technology: An Overview
Table 5: In-Vitro Diagnostic (IVD) Technology
2.6 In-Vitro Diagnostic (IVD) End Users: An Overview
Table 6: In- Vitro Diagnostic (IVD) End Users
2.7 In-Vitro Diagnostic (IVD) Research Flow: An Overview
Table 7: Flow of IVD Research to a Globally IVD Regulated Industry
3. Global Market Analysis
3.1 Global In-Vitro Diagnostic Market: An Analysis
3.1.1 Global In-Vitro Diagnostic Market by Value
Table 8: Global In-Vitro Diagnostic Market by Value; 2015-2016 (US$ Billion)
Table 9: Global In-Vitro Diagnostic Market by Value; 207-2021; (US$ Billion)
3.1.2 Global In-Vitro Diagnostic Market by Region
Table 10: Global In-Vitro Diagnostic Market by Region; 2016
3.1.3 Global In-Vitro Diagnostic Market by Products
Table 11: Global In-Vitro Diagnostic Market by Products; 2016
3.1.4 Global In-Vitro Diagnostic Market by Technology
Table 12: Global In-Vitro Diagnostic Market by Technology; 2016
3.1.5 Global In-Vitro Diagnostic Market by End Users
Table 13: Global In-Vitro Diagnostic Market by End Users; 2016
3.2 Global In-Vitro Diagnostic Market: Product Analysis
3.2.1 Global In-Vitro Diagnostic Reagents Market by Value
Table 14: Global In-Vitro Diagnostic Reagents Market by Value ; 2015-2016 (US$ Billion)
Table 15: Global In-Vitro Diagnostic Reagents Market by Value ; 2017-2021 (US$ Billion)
3.2.2 Global In-Vitro Diagnostic Instrumentations Market by Value
Table 16: Global In-Vitro Diagnostic Instrumentations Market by Value ; 2015-2016 (US$ Billion)
Table 17: Global In-Vitro Diagnostic Instrumentations Market by Value ; 2017-2021 (US$ Billion)
3.3 Global In-Vitro Diagnostic Market: Technology Analysis
3.3.1 Global In-Vitro Diagnostic Self Monitoring Blood Glucose (SMBG) Market by Value
Table 18: Global In-Vitro Diagnostic Self Monitoring Blood Glucose (SMBG) Market by Value; 2016-2021 (US$ Billion)
3.3.2 Global In-Vitro Diagnostic Clinical Chemistry Market by Value
Table 19: Global In-Vitro Diagnostic Clinical Chemistry Market by Value; 2016-2021 (US$ Billion)
3.3.3 Global In-Vitro Diagnostic Immunodiagnostic Market by Value
Table 20: Global In-Vitro Diagnostic Immunodiagnostic Market by Value; 2016-2021 (US$ Billion)
3.3.4 Global In-Vitro Diagnostic Molecular Diagnostic Market by Value
Table 21: Global In-Vitro Diagnostic Molecular Diagnostic Market by Value; 2016-2021 (US$ Billion)
3.3.5 Global In-Vitro Diagnostic Point of Care (POC) Market by Value
Table 22: Global In-Vitro Diagnostic Point of Care (POC) Market by Value; 2016-2021 (US$ Billion)
3.3.6 Global In-Vitro Diagnostic Microbiology Market by Value
Table 23: Global In-Vitro Diagnostic Microbiology Market by Value; 2016-2021 (US$ Billion)
3.3.7 Global In-Vitro Diagnostic Hematology Market by Value
Table 24: Global In-Vitro Diagnostic Hematology Market by Value; 2016-2021 (US$ Billion)
4. Regional Market Analysis
4.1 The US In-Vitro Diagnostic Market: An Analysis
4.1.1 The US In-Vitro Diagnostic Market by Value
Table 25: The US In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
4.2 Europe In-Vitro Diagnostic Market: An Analysis
4.2.1 Europe In-Vitro Diagnostic Market by Value
Table 26: Europe In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
4.3 Asia In-Vitro Diagnostic Market: An Analysis
4.3.1 Asia In-Vitro Diagnostic Market by Value
Table 27: Asia In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
4.3.2 China In-Vitro Diagnostic Market by Value
Table 28: China In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
4.4 ROW In-Vitro Diagnostic Market: An Analysis
4.4.1 ROW In-Vitro Diagnostic Market by Value
Table 29: ROW In-Vitro Diagnostic Market by Value; 2016-2021 (US$ Billion)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Geriatric Population
Table 30: Global Population Proportion Above 65 Years of Age; 2012-2016 (Billion)
5.1.2 Increasing Global Disposable Income
Table 31: Global GNI Per Capita and GNI Per Capita Growth Rate; 2010-2016 (US$)
5.1.3 Increase In Obese Population
Table 32: Global Obese Population; 2012-2016 (Million)
5.1.4 Rising Diabetic Population
Table 33: Global Diabetic Population; 2012-2016 (Million)
5.1.5 Rising Global Healthcare Expenditure
Table 34: Global Healthcare Expenditure; 2013-2018 (US$ Trillion)
5.1.6 Upsurge in Global Urban Population
Table 35: Global Urban Population; 2012-2016 (Billion)
5.2 Challenges
5.2.1 Ethical Issues
5.2.2 Lack of Proper Infrastructure
5.2.3 High Implementation Cost Involved
5.2.4 Stringent Government Regulations
5.3 Market Trends
5.3.1 Emerging Trend of Personalized medicine
5.3.2 Point-of-Care (POC) Technologies
5.3.3 Use of Biochips in IVD
6. Competitive Landscape
6.1 Global In-Vitro Diagnostic Market Players By Share
Table 36: Global In-Vitro Diagnostic Market Players By Share; 2016
6.2 China In-Vitro Diagnostic Market Players By Share
Table 37: Global In-Vitro Diagnostic Market Players By Share; 2016
7. Company Profiles
7.1 Roche Holding
7.1.1 Business Overview
7.1.2 Financial Overview
Table 38: Roche Holding Sales; 2012-2016 (US$ Billion)
Table 39: Roche Holding Sales by Segments; 2016
Table 40: Roche Holding Sales by Region; 2016
7.1.3 Business Strategy
7.2 Danaher Corporation
7.2.1 Business Overview
7.2.2 Financial Overview
Table 41: Danaher Corporation Sales; 2012-2016 (US$ Billions)
Table 42: Danaher Corporation Sales by Segment; 2016
Table 43: Danaher Corporation Sales by Region; 2016
7.2.3 Business Strategy
7.3 Abbott Laboratories
7.3.1 Business Overview
7.3.2 Financial Overview
Table 44: Abbott Laboratories Net Sales; 2012-2016 (US$ Billion)
Table 45: Abbott Laboratories Net Sales by Segments; 2016
Table 46: Abbott Laboratories Net Sales by Region; 2016
7.3.3 Business Strategy
7.4 Siemens Group
7.4.1 Business Overview
7.4.2 Financial Overview
Table 47: Siemens Group Revenue; 2012-2016 (US$ Billion)
Table 48: Siemens Group Revenue By Segment; 2016 (Percentage, %)
Table 49: Siemens Group Revenue By Region; 2016
7.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report